Ana Santos Rutschman
Biographic Data
| ID | 6167474 |
|---|---|
| NAME | Ana Santos Rutschman |
| GIVEN NAMES | Ana Santos |
| FAMILY NAME | Rutschman |
| SIGNATURE | RUTSCHMAN A S |
| AFFILIATIONS | Institute for Vaccine Science and Policy, Saint Louis University, Saint Louis, Missouri, USA |
| ORCID | 0000-0002-4287-6954 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Mapping Intellectual Property Abuses in the Pharmaceutical Field
This Viewpoint details intellectual property abuses in the pharmaceutical industy involving patents, trademarks, copyrights, and trade secrets
Assessment of the proposed intellectual property waiver as a mechanism to address the Covid-19 vaccine scarcity problem
Is There a Cure for Vaccine Nationalism
The scramble among nations for limited supplies of COVID-19 vaccines has drawn attention to long-standing inequities in public health between the global North and South. The COVID-19 Vaccine Global Access Facility (COVAX) is one of several initiatives to pool resources to acquire vaccines for lower-income countries and coordinate distribution. But months before any vaccine had been approved, high-income countries accounting for only a fraction of…
No prominent works on this page.
Is There a Cure for Vaccine Nationalism
The scramble among nations for limited supplies of COVID-19 vaccines has drawn attention to long-standing inequities in public health between the global North and South. The COVID-19 Vaccine Global Access Facility (COVAX) is one of several initiatives to pool resources to acquire vaccines for lower-income countries and coordinate distribution. But months before any vaccine had been approved, high-income countries accounting for only a fraction of…
Assessment of the proposed intellectual property waiver as a mechanism to address the Covid-19 vaccine scarcity problem
Mapping Intellectual Property Abuses in the Pharmaceutical Field
This Viewpoint details intellectual property abuses in the pharmaceutical industy involving patents, trademarks, copyrights, and trade secrets
Coronavirus disease 2019 (COVID-19) (2 works) · Economics (2 works) · Intellectual property (2 works) · Law (2 works) · Medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Political science (2 works) · 2019-20 coronavirus outbreak (1 work) · Access to medicines (1 work) · Biosimilars and Bioanalytical Methods (1 work)